Bank Of Montreal »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Bank Of Montreal

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Bank Of Montreal from 13F filings

Historical chart of Bank Of Montreal investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Bank Of Montreal consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Bank Of Montreal

Quarter filed Position value Share count Share price at filing
2025-06-30 $6.8M 6.0M 1.14
2024-12-31 $18M 17M 1.08
2024-09-30 $20M 17M 1.19
2023-12-31 $13M 14M 0.93
2023-09-30 $3.6M 3.7M 0.96

More positions owned by Bank Of Montreal

NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Rbc Cad (RY)
Microsoft Corporation (MSFT)
Toronto Dominion Bk Ont Com New (TD)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Bk Nova Cad (BNS)
Netflix (NFLX)
Bank Of Montreal Cadcom (BMO)
Broadcom (AVGO)
Cibc Cad (CM)
Canadian Natural Resources (CNQ)

View all positions for Bank Of Montreal

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Millennium Management
LMR Partners
Calamos Advisors
Camden Asset Management
Balyasny Asset Management
DLD Asset Management
Point72 Asset Management
Davidson Kempner Capital Management
Jpmorgan Chase & Co
Jain Global
Nuveen
Lazard Asset Management
State Street Corporation
Absolute Investment Advisers
Citadel Advisors

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1